DuPont Buys Merck Interest.(E.I. DU PONT de Nemours & Co. acquires Merck & Co.'s interest in their 50/50 joint venture, Du Pont Pharmaceutical Co.)

Chemical Market Reporter, July, 1998

E.I. DU PONT de Nemours & Co. has completed the purchase of Merck & Co.'s interest in their 50/50 joint venture, Du Pont Pharmaceutical Company, for $2.6 billion. Once the deal is complete, the business becomes a part of DuPont life sciences, operating as DuPont Pharmaceuticals.